GRINDEKS JSC
| Company | GRINDEKS JSC |
| Registration number | 40003034935 |
| Industry | Manufacture of basic pharmaceutical products and pharmaceutical preparations, Trade of pharmaceutical goods, Scientific research and development |
| Turnover (EUR) (2008) | 50 000 001 - ... |
| Number of employees (2008) | 501 - 1 000 |
| Export countries | Armenia, Australia, Austria, Azerbaijan, Belarus, Canada, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Georgia, Hungary, India, Ireland, Japan, Kazakhstan, Kyrgyzstan, Lithuania, Moldova, Netherlands, Pakistan, Poland, Russia, Singapore, Spain, Swaziland, Tajikistan, Turkmenistan, Ukraine, United Kingdom, USA, Uzbekistan, and others |
| Export volume (EUR) (2008) | 50 000 001 - ... |
| Address | Krustpils street 53, Rīga, LV-1057, Latvia |
| Phone | +371 67083205, +371 67083252 |
| Fax | +371 67083505 |
| grindeks@grindeks.lv | |
| Web | www.grindeks.lv |
| Contact person, position | Mr Jānis Romanovskis - Chairman of the Board/Director, Ms Laura Junghane - Assistant to the Chairman of the Board |
| Spoken languages | Latvian, Russian, English |
| Head of the company, position | Mr Jānis Romanovskis - Chairman of the Board/Director |
| Year of foundation | 1946 |
| Certificates | ISO 14001, ISO 9001, Good Manufacturing Practice, Good Laboratory Practice |
|
Description of product
Grindeks specialises in cardiovascular, central nervious system and anti-cancer medications.Our brand products Mildronate® and Ftorafur® as well as generics togeather create over 100 effective and safe final dosage forms. Grindeks also manufactures active pharmaceutical ingredients of 16 types. The main products are: mildronate, ftorafur, zopiclone, oxytocine and detomidine. |
|
|
Cooperation interests
Grindeks is able to offer fully integrated set of services – from the pharmaceutical development stage to distribution of products and provide you with long term and customized contract manufacturing solutions. Grindeks has all the necessary resources for ensuring contracted development and manufacturing of active pharmaceutical ingredients (APIs). The brand new APIs Scale-up Laboratory not only provides new opportunities for researching new products, but also creates competence for the manufacturing of products in small batches. Grindeks can offer complicated, multi-stage synthesis of APIs at reasonable prices particularly for niche pharmaceutical products. During last two years Grindeks has made considerable investments in modernization of its plant for manufacturing of solid final dosage forms. We are able to offer high quality contract manufacturing services - raw materials purchasing, quality control, analysis, validation, manufacturing, packaging and logistics. The latest technology fitted plants ensure the manufacture of the highest quality products - tablets, capsules and syrups - in compliance with Good Manufacturing Practice standards. |
|
